share_log

Lifeist Initiates Restructuring Proceedings for CannMart Labs Inc.

Lifeist Initiates Restructuring Proceedings for CannMart Labs Inc.

Lifeist 启动了 CannMart Labs Inc. 的重组程序
GlobeNewswire ·  04/03 08:57

TORONTO, April 03, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that it has commenced restructuring proceedings pursuant to the Bankruptcy and Insolvency Act for one of its wholly owned subsidiaries, CannMart Labs Inc. ("CannMart Labs"). The restructuring of CannMart Labs is part of a broader strategic initiative to enhance the company's operational effectiveness while maintaining its commitment to innovation and growth. It is important to note that this restructuring does not impact CannMart Inc., Lifeist's flagship subsidiary and a leading distributor of licensed and in-house branded adult-use cannabis and cannabis-derived products in Canada.

多伦多,2024年4月3日(环球新闻专线)——利用科学和技术进步建立改变人类健康的突破性企业的健康科技公司Lifeist Wellness Inc.(“Lifeist” 或 “公司”)(多伦多证券交易所股票代码:LFST)(法兰克福:M5B)(OTCMKTS:LFSWF)今天宣布,它已根据《破产和破产法》启动重组程序其全资子公司之一——CannMart Labs Inc.(“CannMart Labs”)。CannMart Labs的重组是更广泛的战略计划的一部分,该计划旨在提高公司的运营效率,同时保持其对创新和增长的承诺。值得注意的是,此次重组不会影响CannMart Inc.,这是Lifeist的旗舰子公司,也是加拿大授权和内部品牌成人用大麻和大麻衍生产品的领先分销商。

"Following a thorough financial and strategic review, we believe that it is in the best interest of shareholders for CannMart Labs alone to enter into restructuring proceedings in order to address its obligations and contributions to Lifeist's balance sheet," said Meni Morim, CEO of Lifeist. "We are fully committed to streamlining the operations of our cannabis divisions to better meet the present moment in the industry and are optimistic that this restructuring of CannMart Labs will allow Lifeist's cannabis operations to unlock greater shareholder value. We expect that these proceedings will have no impact on the day-to-day operations of CannMart Inc. or any of our other operating divisions."

Lifeist首席执行官梅尼·莫里姆表示:“经过全面的财务和战略审查,我们认为,光靠CannMart Labs进入重组程序以解决其对Lifeist资产负债表的义务和贡献,符合股东的最大利益。”“我们完全致力于精简大麻部门的运营,以更好地适应该行业的现状,并乐观地认为,CannMart Labs的重组将使Lifeist的大麻业务能够释放更大的股东价值。我们预计,这些诉讼不会对CannMart Inc.或我们任何其他运营部门的日常运营产生任何影响。”

Following the vote of shareholders at the Company's recent annual general and special meeting rejecting the sale of the CannMart Group, Lifeist's cannabis operating division, management undertook a bottom-up review of the businesses to identify opportunities for optimization and improvement. The decision to restructure CannMart Labs was made with input from advisors and legal counsel, with the objective of achieving sustainable growth toward future profitability for the benefit of all Lifeist shareholders. This strategic move is part of a broader commitment to ensure the long-term success of the public company.

在公司最近的年度股东大会和特别会议上,股东投票拒绝出售Lifeist的大麻运营部门CannMart集团,此后,管理层对这些业务进行了自下而上的审查,以确定优化和改进的机会。重组CannMart Labs的决定是在顾问和法律顾问的意见下做出的,目的是实现可持续增长,实现未来的盈利能力,造福所有Lifeist股东。这一战略举措是确保上市公司长期成功的更广泛承诺的一部分。

While the restructuring does not apply to CannMart Inc., this strategic move aims to optimize operational efficiency and streamline the company's focus in alignment with its long-term vision. The decision to initiate restructuring proceedings for CannMart Labs underscores Lifeist's dedication to adaptability and resilience in navigating the dynamic landscape of the cannabis industry. By optimizing the operational structure of CannMart Labs, Lifeist aims to bolster its ability to deliver innovative wellness solutions that positively impact the lives of its customers.

尽管重组不适用于CannMart Inc.,但这一战略举措旨在优化运营效率并精简公司的重点,使其与其长期愿景保持一致。启动CannMart Labs重组程序的决定凸显了Lifeist在大麻行业动态格局中对适应性和弹性的承诺。通过优化CannMart Labs的运营结构,Lifeist旨在增强其提供创新健康解决方案的能力,从而对客户的生活产生积极影响。

Lifeist remains steadfast in its mission to leverage advancements in science and technology to build breakthrough ventures that transform human wellness. The Company is confident that the restructuring of Labs will further strengthen its position as a leader in the health-tech industry and pave the way for continued growth and innovation.

Lifeist坚定不移地履行其使命,即利用科学和技术的进步来建立突破性企业,改变人类健康。该公司相信,实验室的重组将进一步巩固其作为健康科技行业领导者的地位,并为持续增长和创新铺平道路。

About Lifeist Wellness Inc.

关于 Lifeist Wellness

Sitting at the forefront of the post-pandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: Mikra, a biosciences and consumer wellness company developing and selling innovative products for cellular health; CannMart, which operates a B2B wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards including for CannMart Labs, a BHO extraction facility producing high margin cannabis 2.0 products; and Australian Vapes, one of Australia's largest online retailers of vaporizers and accessories.

Lifeist处于疫情后健康革命的最前沿,利用科学和技术的进步来建立突破性公司,改变人类健康。投资组合业务部门包括:开发和销售细胞健康创新产品的生物科学和消费者健康公司Mikra;CannMart,该公司经营B2B批发分销业务,促进向加拿大省政府控制委员会销售休闲大麻,包括生产高利润大麻2.0产品的BHO提取设施CannMart Labs;以及澳大利亚最大的蒸发器和配件在线零售商之一澳大利亚Vapes。

Information on Lifeist and its businesses can be accessed through the links below:

有关Lifeist及其业务的信息可以通过以下链接访问:

Contact:
Meni Morim
CEO
Lifeist Wellness Inc.
Ph: 647-362-0390
Email: ir@lifeist.com

联系人:
Meni Morim
首席执行官
Lifeist健康公司
Ph:647-362-0390
电子邮件:ir@lifeist.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.

多伦多证券交易所风险投资交易所及其监管服务提供商(该术语在多伦多证券交易所风险投资交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任,也未以任何方式批准或不批准本新闻稿的内容。

Forward Looking Information

前瞻性信息

This news release contains "forward-looking information" within the meaning of applicable securities laws. All statements contained herein that are not historical in nature contain forward-looking information. Forward-looking information can be identified by words or phrases such as "may", "expect", "likely", "should", "would", "plan", "anticipate", "intend", "potential", "proposed", "estimate", "believe" or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions "may" or "will" happen.

本新闻稿包含适用证券法所指的 “前瞻性信息”。此处包含的所有非历史性陈述均包含前瞻性信息。前瞻性信息可以通过单词或短语来识别,例如 “可能”、“期望”、“可能”、“应该”、“将”、“计划”、“预期”、“打算”、“潜在”、“提议”、“估计”、“相信” 或这些术语的否定词、表达方式和语法变体,或某些事件或条件 “可能” 或 “将” 发生的陈述。

The forward-looking information contained herein, including, without limitation, statements related to the contemplated restructuring of CannMart Labs are made as of the date of this news release and are based on assumptions management believed to be reasonable at the time such statements were made, including without limitation, the restructuring can be completed in the short term and, upon completion, achieve the intended economic benefits for the Company, and other wholly-owned subsidiaries can become profitable in the short-term, as well as other considerations that are believed to be appropriate in the circumstances. While we consider these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct. By its nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this news release. Such factors include, without limitation: the inability of the Company to complete a feasible and economic restructuring of CannMart Inc., in a timely manner, if at all, the Company's failure to develop its businesses as anticipated and to realize on the anticipated benefits from its increased focus on its other operating businesses unanticipated changes to current regulations that would adversely impact its businesses, unforeseen developments that would delay its businesses the ability to sell newly developed products, the risk that the expected demand for products in general and those of its businesses in particular does not develop as anticipated and risks relating to the Company's ability to execute its business strategy and the benefits realizable therefrom. Additional risk factors can also be found in the Company's current MD&A filed under the Company's SEDAR+ profile at . Readers are cautioned not to put undue reliance on forward-looking information. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement.

此处包含的前瞻性信息,包括但不限于与CannMart Labs计划重组有关的陈述,均截至本新闻稿发布之日作出,基于管理层在发表此类声明时认为合理的假设,包括但不限于重组可以在短期内完成,重组完成后,实现公司的预期经济利益,其他全资子公司可以在短期内实现盈利,以及其他注意事项据信这在当时情况下是适当的。尽管根据管理层目前获得的信息,我们认为这些假设是合理的,但无法保证此类预期会被证明是正确的。就其性质而言,前瞻性信息受固有的风险和不确定性的影响,这些风险和不确定性可能是一般性的,也可能是具体的,这些风险和不确定性可能导致预期、预测、预测、预测或结论不准确,假设可能不正确,目标、战略目标和优先事项无法实现。各种因素,包括已知和未知的风险,其中许多是我们无法控制的,可能导致实际业绩与本新闻稿中的前瞻性信息存在重大差异。这些因素包括但不限于:公司无法及时(如果有的话)完成对CannMart Inc.的可行经济重组,该公司未能按预期发展业务,也未能实现其越来越关注其他运营业务所带来的预期收益,对现行法规的意外变化将对其业务产生不利影响,不可预见的事态发展将延迟其业务销售新开发产品的能力,预期需求的风险对于总体而言,产品,尤其是其业务的产品未按预期发展,风险与公司执行业务战略的能力及其可带来的收益有关。其他风险因素还可以在公司SEDAR+简介下提交的公司当前的MD&A中找到,网址为。提醒读者不要过分依赖前瞻性信息。除非适用法律要求,否则公司没有义务更新或修改任何前瞻性信息,无论是由于新信息、未来事件还是其他原因。本新闻稿中包含的前瞻性陈述受本警示声明的明确限制。

Source: Lifeist Wellness Inc.

资料来源:Lifeist Wellness


声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发